Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fasted Conditions

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Prophylaxis of Organ Rejection
Interventions
DRUG

Mycophenolate Mofetil

Mycophenolate Mofetil 500 mg Tablet

Trial Locations (1)

78759

CEDRA Clinical Research, Austin

All Listed Sponsors
lead

Roxane Laboratories

INDUSTRY

NCT00894088 - Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fasted Conditions | Biotech Hunter | Biotech Hunter